- NEWS AND VIEWS
Rather than just scrambling neural activity, the psychedelic substance psilocybin also reorganizes brain dynamics so as to align with a person’s context and experiences.
By
-
Stefan Borgwardt
-
Stefan Borgwardt is in the Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck D-23538, Germany.
-
-
Mihai Avram
-
Mihai Avram is in the Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck D-23538, Germany.
-
Classic psychedelic compounds — a group that includes psilocybin, LSD, DMT and mescaline — induce profound alterations in perception, cognition and emotion. These substances have captured scientific and clinical attention, partly because guided treatment with psychedelics can provide rapid and long-lasting relief for people with certain psychiatric conditions, such as major depressive disorder1. However, despite the promise that psychedelics show in the clinic, the neural mechanisms that link their acute effects to lasting therapeutic benefits are poorly understood. Human neuroimaging studies have consistently shown that psychedelics disrupt the brain’s intrinsic functional organization, producing a ‘desynchronized’ state2. Writing in Nature, Stoliker et al.3 provide a compelling new perspective: rather than simply making brain activity noisier, psilocybin reorganizes neural dynamics in relation to a person’s surrounding world.
doi: https://doi.org/10.1038/d41586-026-02377-9
References
Goodwin, G. M. et al. N. Engl. J. Med. 387, 1637–1648 (2022).
Article PubMed Google Scholar
Carhart-Harris, R. L. Brain https://doi.org/10.1093/brain/awag206 (2026).
Article Google Scholar
Stoliker, D. et al. Nature https://doi.org/10.1038/s41586-026-10910-z (2026).
Article Google Scholar
Fox, M. D. & Raichle, M. E. Nature Rev. Neurosci. 8, 700–711 (2007).
Article PubMed Google Scholar
Girn, M. et al. Nature Methods 32, 1543–1554 (2026).
Article Google Scholar
Avram, M. et al. Mol. Psychiatry 30, 1297–1307 (2025).
Article PubMed Google Scholar
Siegel, J. S. et al. Nature 632, 131–138 (2024).
Article PubMed Google Scholar
Daws, R. E. et al. Nature Med. 28, 844–851 (2022).
Article PubMed Google Scholar
Mertens, L. J. et al. JAMA Psychiatry 83, 448–460 (2026).
Article PubMed Google Scholar
Lyons, T. et al. Nature Commun. 17, 3977 (2026).
Article PubMed Google Scholar
Avram, M. et al. Cell Rep. Med. 7, 102791 (2026).
Article PubMed Google Scholar
Download references
Competing Interests
S.B. is the secretary (an unpaid, voluntary position) for the German Society for Psychedelic Research and Therapy (DGPFT) e.V..
Related Articles
-
Read the paper: Psychedelics align brain activity with context
-
A psychedelic state arises from desynchronized brain activity
-
Could psychedelics be fine-tuned to relieve anxiety but skip the ‘trip’?
-
See all News & Views
Subjects
Latest on:
- Neuroscience
- Brain
- Psychiatric disorders
-
Asymmetric prefrontal representations for leader–follower dynamics
Article
-
Wake-activated neuronal populations that regulate sleep drive
Article
-
Psychedelics align brain activity with context
Article
-
Human organoids that mimic brain development grown for years in lab
News
-
A controversial Alzheimer’s surgery is said to reverse symptoms — here’s what scientists know
News Feature
-
Brains of male and female mice recover differently from ketamine
Research Highlight
-
Human organoids that mimic brain development grown for years in lab
News
-
Amygdala astrocyte primary cilium mechanisms contribute to stress behaviours
Article
-
Huge study finds first genetic clues for borderline personality disorder
News